Exicure, Inc.
IL-1 BETA TARGETING SPHERICAL NUCLEIC ACIDS

Last updated:

Abstract:

The invention in some aspects relates to antisense inhibitors of IL1B and related methods of use. The antisense inhibitors may be formulated as a nanoparticle or other type of three dimensional presentation format.

Status:
Application
Type:

Utility

Filling date:

20 Jun 2019

Issue date:

2 Sep 2021